[Immune response to meningococci].
The bacterium Neisseria meningitidis causes serious meningococcal epidemics with a high rate of mortality. The article reviews the immunological aspects with regard to colonization, invasion, and vaccination. Serogroup B polysaccharide gives low or no immunological response. This calls for a special vaccine to protect against the most prevalent meningococcal group in Norway.
Flaegstad
T
T
D001428:Bacterial Vaccines / Q000627:therapeutic use; D006801:Humans; D008585:Meningitis, Meningococcal / Q000453:epidemiology / Q000276:immunology* / Q000517:prevention & control; D009345:Neisseria meningitidis / Q000276:immunology; D009664:Norway
D001428:Bacterial Vaccines
Immunsvar på meningokokker.